Concepedia

Hélène L. Hooimeijer

HL

Statistics

Publications

8

Citations

649

H-Index

8

Active since

2013

Affiliations

University Medical Center Groningen(Current)

Cincinnati Children's Hospital Medical Center

Bayer (Germany)

Medical University of Vienna

Murdoch Children's Research Institute

Hélène L. Hooimeijer is an author at University Medical Center Groningen specializing in pharmacotherapy, pediatrics, and anticoagulation therapy.

ORCID

Publications per year

2013–2022

8

Publications

8

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 315 citations · Full text

, , +13

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)

Philip Connor, Mayte Sánchez van Kammen, Anthonie W.A. Lensing et al. · Blood Advances · 2020 · 114 citations · Full text

, , +17

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

Guy Young, Anthonie W.A. Lensing, Paul Monagle et al. · Journal of Thrombosis and Haemostasis · 2020 · 85 citations · Full text

, , +14

Endothelial Damage in Long-Term Survivors of Childhood Cancer

C. A. J. Brouwer, A. Postma, Hélène L. Hooimeijer et al. · Journal of Clinical Oncology · 2013 · 68 citations · Full text

, , +16

Validation of PROMIS Profile‐29 in adults with hemophilia in the Netherlands

Erna C. van Balen, Lotte Haverman, Shermarke Hassan et al. · Journal of Thrombosis and Haemostasis · 2021 · 27 citations · Full text

, , +12

1–5 of 8